Companion diagnostic immunohistochemistry (IHC) tests do not yet incorporate the tools and principles of laboratory metrology. Basic analytic assay parameters, such as lower limit of detection (LOD) ...
5-Hydroxymethylated Biomarkers in Cell-Free DNA Predict Occult Colorectal Cancer up to 36 Months Before Diagnosis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial A two-arm ...
Researchers from Lund University (Sweden) have investigated the tumor immune microenvironment of primary triple-negative breast cancer using digital image analysis of IHC-stained immune cells. To do ...
Boston Cell Standards, Inc. (BCS), a private company bringing modern Quality tools and practices to Clinical ...
Impact of Bone Metastasis in Stage IV Non–Small Cell Lung Cancer Treated With Durvalumab and Tremelimumab With or Without Chemotherapy: A Retrospective Analysis of the CCTG BR.34 Trial Human epidermal ...
A retrospective, cross-sectional study analyzed national trends of immunohistochemistry (IHC) use in the diagnosis of melanoma. Immunohistochemistry (IHC) has emerged as a clinical tool in skin ...
While receiving a metastatic cancer diagnosis can be overwhelming, it is important to keep in mind that not all cancers are ...
Immunophenotyping helps doctors diagnose and classify specific blood cell cancers, like leukemia and lymphoma, as well as other diseases. Immunophenotyping is a lab test doctors use to identify and ...
Immunoassays combine principles of immunology and chemistry into tests that are used by scientists in practically every discipline, including fields as diverse as molecular biology and environmental ...
Boston Cell Standards enters into final phase of US FDA’s MDDT programme to qualify first-in-industry to standardize cancer diagnostic assays: Boston Wednesday, April 29, 2026, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results